As loss of oral tolerance to gluten is a preceding event for the development of villous atrophy in CeD patients (25, 32), much work has been done to uncover the mechanisms behind this loss of tolerance against gluten and how this pro-inflammatory TH1 CD4 T cell response leads to villous atrophy. The gene discussed is CD4; the disease is cranioectodermal dysplasia.